Detalles de la búsqueda
1.
Dual-energy x-ray absorptiometry assessment of bone health in Australian men with prostate cancer commencing androgen deprivation therapy.
Med J Aust
; 218(3): 126-130, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707898
2.
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Gynecol Oncol
; 154(3): 531-538, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31227223
3.
A mixed methods approach to developing and evaluating oncology trainee education around minimization of adverse events and improved patient quality and safety.
BMC Med Educ
; 16: 91, 2016 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26968519
4.
Five-year survival and clinical correlates among patients with advanced non-small cell lung cancer, melanoma and renal cell carcinoma treated with immune check-point inhibitors in Australian tertiary oncology centres.
Cancer Med
; 12(6): 6788-6801, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404632
5.
New therapeutic opportunities for women with low-grade serous ovarian cancer.
Endocr Relat Cancer
; 29(1): R1-R16, 2021 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636747
6.
Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes.
Cancers (Basel)
; 13(17)2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34503155
7.
BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition.
JCO Precis Oncol
; 2: 1-14, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135122
8.
EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas.
Cancer Res
; 77(16): 4268-4278, 2017 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28646021
Resultados
1 -
8
de 8
1
Próxima >
>>